Omni Star Financial Group, Inc. Novo Nordisk A S Transaction History

Omni Star Financial Group, Inc.

$126 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$87.78 - $105.45 $14,308 - $17,188	163 Added 2.68%	6,255 $647,000
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $138,228 - $303,300	1,520 Added 33.25%	6,092 $554,000
Q2 2023 Jul 24, 2023	BUY	$155.98 - $172.65 $176,881 - $195,785	1,134 Added 32.98%	4,572 $739,000
Q1 2023 May 01, 2023	SELL	$132.34 - $159.14 $451,411 - $542,826	-3,411 Reduced 49.8%	3,438 $547,000
Q4 2022 Jan 20, 2023	BUY	$102.55 - $135.33 $246,325 - $325,062	2,402 Added 54.01%	6,849 $0
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $246,298 - $302,264	2,585 Added 138.83%	4,447 $443,000
Q2 2022 Aug 03, 2022	SELL	$103.24 - $121.81 $16,208 - $19,124	-157 Reduced 7.78%	1,862 $207,000
Q1 2022 May 05, 2022	SELL	$93.1 - $112.54 $127,453 - $154,067	-1,369 Reduced 40.41%	2,019 $224,000
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $16,107 - $19,669	168 Added 5.22%	3,388 $379,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $610,103 - $770,542	-7,227 Reduced 69.18%	3,220 $309,000
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $1.18 Million - $1.33 Million	-17,603 Reduced 62.76%	10,447 $704,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $141,644 - $163,614	2,217 Added 8.58%	28,050 $1.96 Million
Q3 2020 Oct 22, 2020	BUY	$63.69 - $70.22 $5,732 - $6,319	90 Added 0.35%	25,833 $1.79 Million
Q2 2020 Jul 06, 2020	BUY	$58.54 - $67.94 $79,029 - $91,719	1,350 Added 5.53%	25,743 $1.69 Million
Q1 2020 Apr 27, 2020	SELL	$49.46 - $64.78 $1.9 Million - $2.49 Million	-38,419 Reduced 61.17%	24,393 $1.47 Million
Q4 2019 Jan 13, 2020	SELL	$49.86 - $58.26 $123,154 - $143,902	-2,470 Reduced 3.78%	62,812 $3.64 Million
Q3 2019 Oct 11, 2019	BUY	$47.54 - $53.43 $9,698 - $10,899	204 Added 0.31%	65,282 $3.38 Million
Q2 2019 Jul 30, 2019	BUY	$46.79 - $52.47 $49,831 - $55,880	1,065 Added 1.66%	65,078 $3.32 Million
Q1 2019 Apr 12, 2019	BUY	$46.36 - $52.63 $1.26 Million - $1.43 Million	27,116 Added 73.49%	64,013 $3.35 Million
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $385,823 - $438,858	-9,288 Reduced 20.11%	36,897 $1.7 Million
Q3 2018 Nov 16, 2018	BUY	$46.76 - $51.24 $14,074 - $15,423	301 Added 0.66%	46,185 $2.18 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $1.06 Million - $1.2 Million	-23,839 Reduced 34.19%	45,884 $2.12 Million
Q1 2018 May 11, 2018	SELL	$48.49 - $58.14 $335,114 - $401,805	-6,911 Reduced 9.02%	69,723 $3.44 Million
Q4 2017 Mar 13, 2018	BUY	$47.53 - $53.73 $3.64 Million - $4.12 Million	76,634	76,634 $4.11 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.

Account